New Age Alpha Advisors LLC Purchases 31,052 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

New Age Alpha Advisors LLC lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 147,866.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 31,073 shares of the healthcare conglomerate's stock after purchasing an additional 31,052 shares during the quarter. UnitedHealth Group makes up about 0.6% of New Age Alpha Advisors LLC's investment portfolio, making the stock its 22nd largest position. New Age Alpha Advisors LLC's holdings in UnitedHealth Group were worth $15,719,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of the company. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter worth approximately $25,000. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at $30,000. Promus Capital LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter worth about $32,000. RPg Family Wealth Advisory LLC acquired a new position in UnitedHealth Group in the third quarter valued at about $37,000. Finally, Pillar Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $40,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have issued reports on the company. Cantor Fitzgerald reiterated an "overweight" rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Deutsche Bank Aktiengesellschaft upped their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a research report on Tuesday, December 3rd. Hsbc Global Res raised shares of UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research note on Friday, January 10th. Wells Fargo & Company lowered their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a report on Tuesday, January 28th. Finally, Oppenheimer lifted their target price on UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a research note on Friday, December 6th. Twenty research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Buy" and an average price target of $629.32.

Remove Ads

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Company insiders own 0.33% of the company's stock.

UnitedHealth Group Trading Down 0.0 %

NYSE:UNH traded down $0.25 on Friday, reaching $515.47. The company's stock had a trading volume of 2,378,211 shares, compared to its average volume of 4,268,981. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a market cap of $471.51 billion, a PE ratio of 33.26, a PEG ratio of 1.37 and a beta of 0.62. The business's 50-day moving average price is $508.81 and its two-hundred day moving average price is $544.24.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business's revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $5.83 earnings per share. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.63%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio is presently 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.